Maternal age-specific fetal loss rates in Down syndrome pregnancies

Prenatal Diagnosis
George M SavvaE Alberman

Abstract

Pregnancies affected by Down syndrome (DS) have a greater risk of spontaneous fetal loss than those that are unaffected. In this article, we investigate the relationship between maternal age and the risk of spontaneous fetal loss in DS pregnancies. Fetal loss at different maternal ages were estimated by survival analysis using follow-up of 5177 prenatally diagnosed cases. The maternal age effect on loss rate was subsequently confirmed by a re-analysis of published comparisons of the maternal age-specific prevalence of DS at different gestational ages. The average fetal loss rate between the time of chorionic villus sampling (CVS) and term was 32% (95% CI: 26-38), increasing from 23% (95% CI: 16-31) for women aged 25 to 44% (33-56) for women aged 45. The average fetal loss rate between the time of amniocentesis and term was 25% (21-31), increasing from 19% (14-27) to 33% (26-45) across the same age range. The fetal loss rate in DS pregnancies increases with maternal age, and this has consequences when estimating the live birth prevalence of DS in the presence of prenatal diagnosis and termination, and when assessing the performance of prenatal screening techniques.

References

Nov 15, 1992·American Journal of Medical Genetics·P G KratzerR N Taylor
Nov 23, 1991·BMJ : British Medical Journal·D E MuttonM Bobrow
Oct 1, 1995·British Journal of Obstetrics and Gynaecology·M C MacintoshC Lundsteen
Jul 1, 1994·Prenatal Diagnosis·R J SnijdersK H Nicolaides
Apr 16, 1999·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·R J SnijdersK H Nicolaides
Dec 11, 1999·Prenatal Diagnosis·H Cuckle
Apr 12, 2002·Journal of Medical Screening·J K MorrisE Alberman
Oct 9, 2002·Journal of Medical Screening·E Alberman

❮ Previous
Next ❯

Citations

May 10, 2008·International Journal of Epidemiology·Richard J Q McNallyTanja Pless-Mulloli
Apr 23, 2013·Mediators of Inflammation·Tiago Nunes, Heitor S de Souza
May 7, 2009·Journal of Genetics·Santhosh Girirajan
Jan 5, 2016·Seminars in Perinatology·Britton D Rink, Mary E Norton
Sep 27, 2015·American Journal of Medical Genetics. Part a·Joan K MorrisJennifer Dennis
Mar 31, 2009·Medicina clínica·Carmen Mosquera TenreiroIsolina Riaño Galán
May 29, 2016·Clinics in Laboratory Medicine·Renée L Chard, Mary E Norton
Dec 17, 2010·Pediatrics International : Official Journal of the Japan Pediatric Society·Ivana Babić BožovićBojana Brajenović-Milić
Jun 26, 2010·American Journal of Medical Genetics. Part a·Emanuele LeonciniPierpaolo Mastroiacovo
Nov 19, 2009·American Journal of Medical Genetics. Part a·Elizabeth De SouzaJoan K Morris
Mar 31, 2015·American Journal of Medical Genetics. Part a·Gert de GraafBrian G Skotko
Oct 3, 2012·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Nuri DanismanEsra Sukran Cakar
Apr 30, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Gert de GraafBrian G Skotko
Feb 12, 2011·American Journal of Obstetrics and Gynecology·Mathias EhrichDirk van den Boom
Jun 6, 2007·American Journal of Obstetrics and Gynecology·Dena TownerLinda C Greve
Feb 19, 2016·Prenatal Diagnosis·Teresa N SparksAaron B Caughey
Apr 21, 2016·American Journal of Obstetrics and Gynecology·Mary E NortonLaura L Jelliffe-Pawlowski
Jul 19, 2013·Journal of Health Services Research & Policy·Richard RenshawJoan Morris
Oct 26, 2016·Obstetrics and Gynecology·Teresa N SparksRobert J Currier
May 12, 2016·Revista da Associação Médica Brasileira·Vanessa Vigna GoulartMarcelo Zugaib
Mar 6, 2018·American Journal of Alzheimer's Disease and Other Dementias·Gabriele CiprianiMario Di Fiorino
Jan 14, 2018·European Journal of Human Genetics : EJHG·Maurike D de Groot-van der MoorenMartina C Cornel
Mar 23, 2017·American Journal of Medical Genetics. Part a·Alana Cavadino, Joan K Morris
Feb 23, 2019·Frontiers in Genetics·Ivana Babić BožovićBojana Brajenović-Milić
Nov 30, 2019·BMC Health Services Research·Chanane WanapirakTheera Tongsong
Mar 7, 2017·Journal of Intellectual Disability Research : JIDR·G de GraafE Voorhoeve
Mar 20, 2018·Pediatric Radiology·Kathryn J Gray, Louise E Wilkins-Haug
Feb 8, 2020·Nature Reviews. Disease Primers·Stylianos E AntonarakisRoger H Reeves
Oct 21, 2020·Prenatal Diagnosis·Howard Cuckle, Joan Morris
Dec 10, 2020·Cost Effectiveness and Resource Allocation : C/E·L NshimyumukizaD Reinharz
Jun 27, 2021·Current Opinion in Immunology·Louise Malle, Dusan Bogunovic

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

BJOG : an International Journal of Obstetrics and Gynaecology
Babak KhoshnoodFrançois Goffinet
American Journal of Medical Genetics. Part a
Joan K Morris, George M Savva
European Journal of Public Health
A H BittlesE J Glasson
© 2022 Meta ULC. All rights reserved